Clinical Trials Browser

Phase 3 × Smoldering Multiple Myeloma × dexamethasone 21-phosphate × Clear all

NCT03937635 2026-03-02

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Phase 3 Recruiting

Smoldering Multiple Myeloma